Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2024 10:00 ET | Source: Transparency Market Research

Clinical Trials Support Services Market Size to Reach USD 48.5 billion, at a 8.1 % CAGR By 2033 - Transparency Market Research, Inc.

Wilmington, Delaware, United States, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global clinical trials support services market is estimated to flourish at a CAGR of...
July 07, 2020 06:45 ET | Source: Annovis Bio Inc.

Annovis Bio Receives Institutional Review Board Approval to Initiate 15 Site Phase 2 Study in 68 Parkinson’s and Alzheimer’s Patients

BERWYN, Pa., July 07, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other...
May 30, 2019 17:10 ET | Source: J.D. Irving, Limited

Déclaration d’Irving Shipbuilding

HALIFAX, Nouvelle-Écosse, 30 mai 2019 (GLOBE NEWSWIRE) -- Nous respectons entièrement la liberté des journalistes, qui ont le droit de poser des questions. Irving Shipbuilding a donné des...
May 30, 2019 17:10 ET | Source: J.D. Irving, Limited

Statement From Irving Shipbuilding

HALIFAX, Nova Scotia, May 30, 2019 (GLOBE NEWSWIRE) -- We fully respect all journalists’ responsibility to ask questions. Irving Shipbuilding has given dozens of interviews and has invited media to...
January 24, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Receives Approval to Commence Clinical Study

VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
January 18, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Completes IRB Submission in Preparation for Clinical Study

VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
August 08, 2012 17:00 ET | Source: SANUWAVE Health, Inc.

SANUWAVE Reports Second Quarter 2012 Financial Results and Provides a Business Update

ALPHARETTA, Ga., Aug. 8, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the three and six months ended June 30, 2012 and provided a business...